The Latest Healthcare Services Articles from Streetwise Reports

Telemedicine Co. Surges on Revenue News

  ()
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar.

US Biotech Firm Keeps Growing Revenue

Research Report
  ()
Revenue last quarter was strong, and management expects to increase revenue 20% this fiscal year, noted a ROTH Capital Partners report.

Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World

  ()
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc.

Co. Pursuing Ketamine for Addiction Forms Partnership

Research Report
  ()
In landing this first licensing deal, the life sciences firm "shows good progress towards a potentially high-margin business," noted a Stifel report.

Expert Believes Health Co. Blooms With Opportunity

Contributed Opinion
  ()
Expert Clive Maund touches on the latest news with Bloom Health Partners Inc. from the enthusiastic buying toward the end of June to whether he believes the health company is still bullish.

Biotech Co.'s Phase 3 Trial First to Get Grant

  ()
A revenue-generating junior biotech company based in the U.K. has become the first public company to be approved for a government grant to fund most of a Phase 3 study exploring the use of psychedelics to treat Alcohol Use Disorder. It could be a catalyst for the share price.

Healthcare Co.’s Psychedelic-Assisted Treatments Have ‘Blockbuster Drug Potential’

Research Report
  ()
Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with Alcohol Use Disorder (AUD) or alcoholism. One company hopes to bring its treatments to clinics throughout Europe and become the go-to standard of care for AUD.

Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry

Research Report
  ()
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report.

Analyst Sees 'Attractive Long-Term Economics' for Healthcare Co.

Research Report
  ()
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments.

Healthcare Tech Firm Improves Earnings and Cash Flow in Q3/22

Research Report
  ()
These changes earned Reliq Health Technologies Inc. an upgrade in overall rating by independent investment research and advisory firm, Jefferson Research.

Showing Results: 1 to 17 of 17